A phase 1 study of LJM716 in patients with esophageal squamous cell carcinoma, head and neck cancer, or HER2-overexpressing metastatic breast or gastric cancer.
Kerry Lynn Reynolds
No relevant relationships to disclose
Dejan Juric
No relevant relationships to disclose
Jose Baselga
Consultant or Advisory Role - Novartis; Roche
Maria Alsina
No relevant relationships to disclose
Josep Tabernero
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech; ImClone Systems; Lilly; Merck KGaA; Millennium; Novartis
Honoraria - Amgen; Merck KGaA; Novartis; Roche; Sanofi
Philippe L. Bedard
Consultant or Advisory Role - Novartis
Research Funding - Novartis
Donna M. Graham
No relevant relationships to disclose
Ana M. Gonzalez-Angulo
Consultant or Advisory Role - Novartis (I)
Research Funding - Novartis
Ignacio Garrido-Laguna
No relevant relationships to disclose
Sunil Sharma
Honoraria - Novartis
Research Funding - Novartis
Other Remuneration - Beta Cat Pharmaceuticals; ConverGene; Salarius Pharmaceuticals
Chia-Chi Lin
Honoraria - Novartis
Ezra E.W. Cohen
Consultant or Advisory Role - Novartis
Se-Hoon Lee
Consultant or Advisory Role - Bayer; GlaxoSmithKline; Janssen; Novartis; Pfizer
Honoraria - Pfizer
Expert Testimony - Janssen; Pfizer
Mauro Zucchetto
Employment or Leadership Position - Novartis
Xianbin Tian
Employment or Leadership Position - Novartis
Lily Delgado
Employment or Leadership Position - Novartis
Jian Li
Employment or Leadership Position - Novartis Institute for Biomedical Research
Alex Morozov
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Yung-Jue Bang
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Research Funding - Novartis